WORLDTECHStartups & Business SINGLE SOURCE
Ghent-based SpectaCell launches with €6 million to advance its cell analysis platform for immunotherapy development
First reported Source: EU-StartupsLast editorial activity
What happened
SpectaCell, a new Ghent-based startup specialising in next-generation cell therapy analytics, has announced its official launch with €6 million in Seed funding. Tony Montoye, CEO […] The post Ghent-based SpectaCell launches with €6 million to advance its cell analysis platform for immunotherapy development appeared first on EU-Startups .
The company has spun out of imec, VIB and Ghent University. The round was led by imec.xpand, with participation from PMV’s Flanders Future Tech Fund, InnovationQuarter Capital, Qbic and VIB.
Sources & evidence
- EU-Startups Reporting source
Ghent-based SpectaCell launches with €6 million to advance its cell analysis platform for immunotherapy development ↗
https://www.eu-startups.com/2026/10/ghent-based-spectacell-launches-with-e6-million-to-advance-its-cell-analysis-platform-for-immunotherapy-development/